Your browser doesn't support javascript.
loading
Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity.
O'Mara, Alana E; Johnson, James W; Linderman, Joyce D; Brychta, Robert J; McGehee, Suzanne; Fletcher, Laura A; Fink, Yael A; Kapuria, Devika; Cassimatis, Thomas M; Kelsey, Nathan; Cero, Cheryl; Sater, Zahraa Abdul; Piccinini, Francesca; Baskin, Alison S; Leitner, Brooks P; Cai, Hongyi; Millo, Corina M; Dieckmann, William; Walter, Mary; Javitt, Norman B; Rotman, Yaron; Walter, Peter J; Ader, Marilyn; Bergman, Richard N; Herscovitch, Peter; Chen, Kong Y; Cypess, Aaron M.
Afiliación
  • O'Mara AE; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Johnson JW; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Linderman JD; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Brychta RJ; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • McGehee S; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Fletcher LA; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Fink YA; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Kapuria D; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland, USA.
  • Cassimatis TM; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Kelsey N; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Cero C; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Sater ZA; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Piccinini F; Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Baskin AS; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Leitner BP; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Cai H; Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland, USA.
  • Millo CM; Positron Emission Tomography Department, NIH, Bethesda, Maryland, USA.
  • Dieckmann W; Positron Emission Tomography Department, NIH, Bethesda, Maryland, USA.
  • Walter M; Clinical Laboratory Core, NIDDK, NIH, Bethesda, Maryland, USA.
  • Javitt NB; Departments of Medicine and Pediatrics, NYU School of Medicine, New York, New York, USA.
  • Rotman Y; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland, USA.
  • Walter PJ; Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland, USA.
  • Ader M; Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Bergman RN; Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Herscovitch P; Positron Emission Tomography Department, NIH, Bethesda, Maryland, USA.
  • Chen KY; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
  • Cypess AM; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
J Clin Invest ; 130(5): 2209-2219, 2020 05 01.
Article en En | MEDLINE | ID: mdl-31961826
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tiazoles / Tejido Adiposo Pardo / Resistencia a la Insulina / Tomografía Computarizada por Tomografía de Emisión de Positrones / HDL-Colesterol / Acetanilidas Tipo de estudio: Diagnostic_studies Límite: Adolescent / Adult / Female / Humans Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tiazoles / Tejido Adiposo Pardo / Resistencia a la Insulina / Tomografía Computarizada por Tomografía de Emisión de Positrones / HDL-Colesterol / Acetanilidas Tipo de estudio: Diagnostic_studies Límite: Adolescent / Adult / Female / Humans Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos